Home Shop Reveromycin A

Inquire for Availability

Reveromycin A

ALX-380-216

Datasheet
Manual
SDS
CofA

Already have an account?

Cell cycle inhibitor

Antibiotic. Dominant analog of the reveromycin complex. Inhibitor of the mitogenic activity of epidermal growth factor (EGF). G1 phase cell cycle inhibitor, selectively inhibiting isoleucyl-tRNA synthetase. Displays antiproliferative as well as potent antifungal activity. Induces apoptosis in osteoclasts thus inhibiting bone resorption.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Product Details

Appearance	White to tan solid.
CAS	134615-37-5
Couple Target	EGF, Isoleucyl-tRNA synthetase
Couple Type	Inhibitor
Formula	C₃₆H₅₂O₁₁
Formulation	Lyophilized.
MW	660.8
Purity	≥99% (HPLC)
Solubility	Soluble in ethyl acetate, 100% ethanol, methanol, dimethyl formamide or DMSO.
Source	Isolated from Streptomyces sp. MST-AS5344.

Handling & Storage

Use/Stability	As indicated on product label or CoA when stored as recommended.
Long Term Storage	-20°C
Shipping	Ambient Temperature

Regulatory Status	RUO – Research Use Only

Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone: S. Sone and S. Yano; Cancer Metastasis Rev. 26, 685 (2007), Abstract
Regulation of osteoclast polarization: N. Takahashi, et al.; Odontology 95, 1 (2007), (Review), Abstract
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts: J.T. Woo, et al.; PNAS 103, 4729 (2006), Abstract — Full Text
Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity: H. Muguruma, et al.; Clin. Cancer Res. 11, 8822 (2005), Abstract — Full Text
Chemical modification of reveromycin A and its biological activities: T. Shimizu, et al.; Bioorg. Med. Chem. Lett. 12, 3363 (2002), Abstract
Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A: Y. Miyamoto, et al.; J. Biol. Chem. 277, 28810 (2002), Abstract — Full Text
Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties: H. Takahashi, et al.; J. Antibiot. (Tokyo) 45, 1409 (1992), Abstract
Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities: H. Takahashi, et al.; J. Antibiot. (Tokyo) 45, 1414 (1992), Abstract

Related Products

Available

(+)-Aphidicolin

BML-CC101

Reversible inhibitor of DNA polymerase a and d

21 citations

CAS	38966-21-1
Couple Type	Inhibitor
Purity	≥98% (TLC)

Inquire for Availability

(-)-Arctigenin

ALX-350-312

Antitumor agent

9 citations

Alternative Name	(3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-(3H)-furanone
CAS	7770-78-7
Couple Type	Inhibitor
Purity	≥97% (HPLC)

Inquire for Availability

(-)-Arctiin

ALX-350-318

Antitumor agent

8 citations

Alternative Name	(3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]-3-[[4-(β-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-2(3H)-furanone
CAS	20362-31-6
Couple Type	Inhibitor
Purity	≥95% (HPLC)

Available

(-)-Epigallocatechin gallate

ALX-270-263

Inhibitor of NOS, telomerase and Dnmt

36 citations

Alternative Name	EGCG, (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
CAS	989-51-5
Couple Type	Inhibitor
Purity	≥98% (HPLC)

Last modified: May 29, 2024

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Datasheet

Certificate of Analysis

Please enter the lot number as featured on the product label

Lot No. :

SDS

Enzo Life Science provides GHS Compliant SDS

If your language is not available please fill out the SDS request form

Your Cart

Your Cart

Reveromycin A

ALX-380-216

Product Details

Handling & Storage

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Certificate of Analysis

SDS

Change Country

Tell us about You

Tell us about your paper

Tell us about You

Tell us about your project